|
2024-12-03 |
2024-12-02 |
PS
Planned sale
|
Carson Seana
EVP, General Counsel
Officer
|
440
-0.1%
8.35
USD 3,674
|
440
-0.1%
|
8.35
|
USD 3,674
|
|
|
2024-09-09 |
2024-09-06 |
PS
Planned sale
|
Carson Seana
EVP, General Counsel
Officer
|
13,370
-3.0%
6.21
USD 83,028
|
13,370
-3.0%
|
6.21
|
USD 83,028
|
|
|
2024-09-09 |
2024-09-06 |
S
Sale
|
Carson, Seana Lynne
Senior Officer of Issuer
Officer
|
13,370
-10.0%
6.21
USD 83,028
|
13,370
-10.0%
|
6.21
|
USD 83,028
|
|
|
2024-03-04 |
2024-03-04 |
PS
Planned sale
|
Carson Seana
EVP, General Counsel
Officer
|
133
-0.0%
9.80
USD 1,303
|
133
-0.0%
|
9.80
|
USD 1,303
|
|
|
2024-03-04 |
2024-03-04 |
PS
Planned sale
|
Carson Seana
EVP, General Counsel
Officer
|
1,561
-0.3%
9.80
USD 15,298
|
1,561
-0.3%
|
9.80
|
USD 15,298
|
|
|
2024-03-04 |
2024-03-04 |
PS
Planned sale
|
Carson Seana
EVP, General Counsel
Officer
|
199
-0.0%
9.80
USD 1,950
|
199
-0.0%
|
9.80
|
USD 1,950
|
|
|
2024-03-04 |
2024-03-04 |
PS
Planned sale
|
Carson Seana
EVP, General Counsel
Officer
|
4,420
-0.9%
9.80
USD 43,316
|
4,420
-0.9%
|
9.80
|
USD 43,316
|
|
|
2023-12-05 |
2023-12-05 |
PS
Planned sale
|
Carson Seana
EVP, General Counsel
Officer
|
220
-0.1%
7.38
USD 1,624
|
220
-0.1%
|
7.38
|
USD 1,624
|
|
|
2023-11-07 |
2023-11-06 |
S
Sale
|
Carson, Seana Lynne
Senior Officer of Issuer
Officer
|
43
-0.1%
7.61
USD 327
|
43
-0.1%
|
7.61
|
USD 327
|
|
|
2023-11-06 |
2023-11-06 |
PS
Planned sale
|
Carson Seana
EVP, General Counsel
Officer
|
43
-0.0%
7.61
USD 327
|
43
-0.0%
|
7.61
|
USD 327
|
|
|
2023-09-06 |
2023-09-06 |
PS
Planned sale
|
Carson Seana
EVP, General Counsel
Officer
|
6,685
-1.7%
8.28
USD 55,352
|
6,685
-1.7%
|
8.28
|
USD 55,352
|
|
|
2023-03-01 |
2023-02-28 |
PS
Planned sale
|
Carson Seana
EVP, General Counsel
Officer
|
292
-0.1%
9.32
USD 2,721
|
292
-0.1%
|
9.32
|
USD 2,721
|
|
|
2022-04-15 |
2022-04-14 |
PS
Planned sale
|
Spurr Robert
U.S. President-Pharma Business
Officer
|
1,595
-1.7%
22.19
USD 35,393
|
1,595
-1.7%
|
22.19
|
USD 35,393
|
|
|
2022-03-16 |
2022-03-15 |
PS
Planned sale
|
Spurr Robert
U.S. President-Pharma Business
Officer
|
4,846
-5.0%
22.20
USD 107,581
|
4,846
-5.0%
|
22.20
|
USD 107,581
|
|
|
2022-03-10 |
2022-03-08 |
PS
Planned sale
|
Gordon Joseph F
Pres&Co-Head Bausch&Lomb/Int'l
Officer
|
3,889
-4.0%
21.76
USD 84,625
|
3,889
-4.0%
|
21.76
|
USD 84,625
|
|
|
2022-03-04 |
2022-03-02 |
PS
Planned sale
|
Gordon Joseph F
Pres&Co-Head Bausch&Lomb/Int'l
Officer
|
11,077
-9.9%
23.37
USD 258,869
|
11,077
-9.9%
|
23.37
|
USD 258,869
|
|
|
2022-03-04 |
2022-03-02 |
PS
Planned sale
|
Spurr Robert
U.S. President-Pharma Business
Officer
|
1,595
-2.4%
23.37
USD 37,275
|
1,595
-2.4%
|
23.37
|
USD 37,275
|
|
|
2022-03-02 |
2022-03-01 |
PS
Planned sale
|
Gordon Joseph F
Pres&Co-Head Bausch&Lomb/Int'l
Officer
|
6,338
-5.3%
23.82
USD 150,971
|
6,338
-5.3%
|
23.82
|
USD 150,971
|
|
|
2022-02-17 |
2022-02-15 |
PS
Planned sale
|
Spurr Robert
U.S. President-Pharma Business
Officer
|
3,251
-5.1%
25.02
USD 81,340
|
3,251
-5.1%
|
25.02
|
USD 81,340
|
|
|
2022-01-20 |
2022-01-18 |
PS
Planned sale
|
Spurr Robert
U.S. President-Pharma Business
Officer
|
3,251
-4.9%
26.63
USD 86,574
|
3,251
-4.9%
|
26.63
|
USD 86,574
|
|
|
2021-12-02 |
2021-11-30 |
B
Purchase
|
Miller Steven D
Non-Executive Director
|
10,000
+inf%
24.17
USD 241,699
|
10,000
+inf%
|
24.17
|
USD 241,699
|
|
|
2021-12-02 |
2021-11-30 |
B
Purchase
|
Miller Steven D
Non-Executive Director
|
50,000
+463.8%
24.24
USD 1,211,825
|
50,000
+463.8%
|
24.24
|
USD 1,211,825
|
|
|
2021-06-15 |
2021-06-11 |
S
Sale
|
Eldessouky Sam
EVP & Chief Financial Officer
Officer
|
17,000
-12.7%
31.68
USD 538,586
|
17,000
-12.7%
|
31.68
|
USD 538,586
|
|
|
2020-12-08 |
2020-12-04 |
S
Sale
|
Humphries William D.
President, Ortho-Dermatologics
Officer
|
114,055
-32.7%
19.87
USD 2,266,398
|
114,055
-32.7%
|
19.87
|
USD 2,266,398
|
|
|
2020-11-30 |
2020-11-27 |
S
Sale
|
Humphries William D.
President, Ortho-Dermatologics
Officer
|
13,663
-5.5%
19.63
USD 268,207
|
13,663
-5.5%
|
19.63
|
USD 268,207
|
|
|
2020-11-30 |
2020-11-24 |
S
Sale
|
Humphries William D.
President, Ortho-Dermatologics
Officer
|
21,658
-8.4%
19.63
USD 425,196
|
21,658
-8.4%
|
19.63
|
USD 425,196
|
|
|
2020-11-30 |
2020-11-23 |
S
Sale
|
Humphries William D.
President, Ortho-Dermatologics
Officer
|
1,483
-0.6%
19.63
USD 29,115
|
1,483
-0.6%
|
19.63
|
USD 29,115
|
|
|
2020-09-10 |
2020-09-08 |
PS
Planned sale
|
Humphries William D.
President, Ortho-Dermatologics
Officer
|
5,667
-2.4%
16.17
USD 91,635
|
5,667
-2.4%
|
16.17
|
USD 91,635
|
|
|
2020-06-09 |
2020-06-05 |
B
Purchase
|
ValueAct Holdings, L.P.
See Remarks
Non-Executive Director
|
948,353
+5.6%
19.24
USD 18,246,312
|
948,353
+5.6%
|
19.24
|
USD 18,246,312
|
|
|
2020-06-09 |
2020-06-05 |
S
Sale
|
ValueAct Holdings, L.P.
See Remarks
Non-Executive Director
|
948,353
-100.0%
19.24
USD 18,246,312
|
948,353
-100.0%
|
19.24
|
USD 18,246,312
|
|
|
2020-05-14 |
2020-05-14 |
B
Purchase
|
Paulson John
Non-Executive Director
|
585,100
+2.3%
15.92
USD 9,314,792
|
585,100
+2.3%
|
15.92
|
USD 9,314,792
|
|
|
2020-05-14 |
2020-05-14 |
B
Purchase
|
Paulson John
Non-Executive Director
|
624,900
+2.5%
15.87
USD 9,917,163
|
624,900
+2.5%
|
15.87
|
USD 9,917,163
|
|
|
2020-05-14 |
2020-05-14 |
B
Purchase
|
Paulson John
Non-Executive Director
|
70,000
+0.3%
15.65
USD 1,095,500
|
70,000
+0.3%
|
15.65
|
USD 1,095,500
|
|
|
2020-05-14 |
2020-05-14 |
B
Purchase
|
Paulson John
Non-Executive Director
|
348,920
+1.4%
15.85
USD 5,530,382
|
348,920
+1.4%
|
15.85
|
USD 5,530,382
|
|
|
2020-05-14 |
2020-05-13 |
B
Purchase
|
Paulson John
Non-Executive Director
|
645,844
+2.7%
16.70
USD 10,785,595
|
645,844
+2.7%
|
16.70
|
USD 10,785,595
|
|
|
2020-05-14 |
2020-05-13 |
B
Purchase
|
Paulson John
Non-Executive Director
|
80,300
+0.3%
16.58
USD 1,331,374
|
80,300
+0.3%
|
16.58
|
USD 1,331,374
|
|
|
2020-05-14 |
2020-05-13 |
B
Purchase
|
Paulson John
Non-Executive Director
|
603,900
+2.6%
16.32
USD 9,855,648
|
603,900
+2.6%
|
16.32
|
USD 9,855,648
|
|
|
2020-05-14 |
2020-05-12 |
B
Purchase
|
Paulson John
Non-Executive Director
|
799,900
+3.6%
17.24
USD 13,790,276
|
799,900
+3.6%
|
17.24
|
USD 13,790,276
|
|
|
2020-05-14 |
2020-05-12 |
B
Purchase
|
Paulson John
Non-Executive Director
|
678,400
+3.2%
17.47
USD 11,851,648
|
678,400
+3.2%
|
17.47
|
USD 11,851,648
|
|
|
2020-05-14 |
2020-05-12 |
B
Purchase
|
Paulson John
Non-Executive Director
|
374,836
+1.8%
17.33
USD 6,495,908
|
374,836
+1.8%
|
17.33
|
USD 6,495,908
|
|
|
2020-05-14 |
2020-05-12 |
B
Purchase
|
Paulson John
Non-Executive Director
|
162,900
+0.8%
17.50
USD 2,850,750
|
162,900
+0.8%
|
17.50
|
USD 2,850,750
|
|
|
2020-05-14 |
2020-05-12 |
B
Purchase
|
Paulson John
Non-Executive Director
|
25,000
+0.1%
17.30
USD 432,500
|
25,000
+0.1%
|
17.30
|
USD 432,500
|
|
|
2020-03-16 |
2020-03-12 |
B
Purchase
|
Ross Thomas W. Sr.
Non-Executive Director
|
2,500
+3.3%
15.54
USD 38,838
|
2,500
+3.3%
|
15.54
|
USD 38,838
|
|
|
2020-03-11 |
2020-03-10 |
B
Purchase
|
VON ESCHENBACH ANDREW C.
Non-Executive Director
|
1,100
+6.3%
18.18
USD 19,996
|
1,100
+6.3%
|
18.18
|
USD 19,996
|
|
|
2020-03-11 |
2020-03-10 |
B
Purchase
|
ACKERMANN CHRISTINA
EVP AND GENERAL COUNSEL
Officer
|
4,390
+5.0%
18.25
USD 80,106
|
4,390
+5.0%
|
18.25
|
USD 80,106
|
|
|
2020-03-11 |
2020-03-10 |
B
Purchase
|
DE SCHUTTER RICHARD U
Non-Executive Director
|
3,800
+38.0%
18.26
USD 69,377
|
3,800
+38.0%
|
18.26
|
USD 69,377
|
|
|
2020-03-11 |
2020-03-03 |
B
Purchase
|
DE SCHUTTER RICHARD U
Non-Executive Director
|
5,000
+1.8%
23.08
USD 115,415
|
5,000
+1.8%
|
23.08
|
USD 115,415
|
|
|
2019-09-13 |
2019-09-13 |
B
Purchase
|
PAPA JOSEPH C
CHAIRMAN & CEO
Executive Director
|
30,000
+3.7%
23.31
USD 699,300
|
30,000
+3.7%
|
23.31
|
USD 699,300
|
|
|
2019-08-21 |
2019-08-19 |
S
Sale
|
McKenna Mark C.
President, Salix
Officer
|
10,773
-34.2%
21.83
USD 235,221
|
10,773
-34.2%
|
21.83
|
USD 235,221
|
|
|
2019-08-20 |
2019-08-16 |
B
Purchase
|
Humphries William D.
President, Ortho-Dermatologics
Officer
|
30,703
+26.2%
21.18
USD 650,142
|
30,703
+26.2%
|
21.18
|
USD 650,142
|
|
|
2019-08-13 |
2019-08-12 |
PS
Planned sale
|
ACKERMANN CHRISTINA
EVP AND GENERAL COUNSEL
Officer
|
3,418
-6.3%
22.45
USD 76,726
|
3,418
-6.3%
|
22.45
|
USD 76,726
|
|
|
2019-07-15 |
2019-07-11 |
PS
Planned sale
|
ACKERMANN CHRISTINA
EVP AND GENERAL COUNSEL
|
3,968
-6.0%
24.81
USD 98,446
|
3,968
-6.0%
|
24.81
|
USD 98,446
|
|
|
2019-02-28 |
2019-02-28 |
B
Purchase
|
PAPA JOSEPH C
CHAIRMAN & CEO
Executive Director
|
30,000
+4.4%
23.67
USD 710,100
|
30,000
+4.4%
|
23.67
|
USD 710,100
|
|
|
2018-12-18 |
2018-12-14 |
B
Purchase
|
APPIO THOMAS
Pres&Co-Head Bausch&Lomb/Int'l
Officer
|
25,440
+24.6%
22.96
USD 584,018
|
25,440
+24.6%
|
22.96
|
USD 584,018
|
|
|
2018-10-17 |
2018-10-16 |
PS
Planned sale
|
ACKERMANN CHRISTINA
EVP AND GENERAL COUNSEL
Officer
|
4,542
-8.1%
25.50
USD 115,821
|
4,542
-8.1%
|
25.50
|
USD 115,821
|
|
|
2018-10-17 |
2018-10-15 |
PS
Planned sale
|
ACKERMANN CHRISTINA
EVP AND GENERAL COUNSEL
Officer
|
15,404
-21.6%
24.83
USD 382,481
|
15,404
-21.6%
|
24.83
|
USD 382,481
|
|
|
2018-09-17 |
2018-09-14 |
B
Purchase
|
PAPA JOSEPH C
CHAIRMAN & CEO
Executive Director
|
30,000
+4.8%
22.32
USD 669,600
|
30,000
+4.8%
|
22.32
|
USD 669,600
|
|
|
2018-09-17 |
2018-09-14 |
B
Purchase
|
Herendeen Paul
EVP and CFO
Officer
|
10,000
+4.8%
22.61
USD 226,100
|
10,000
+4.8%
|
22.61
|
USD 226,100
|
|
|
2018-09-17 |
2018-09-13 |
B
Purchase
|
DE SCHUTTER RICHARD U
Non-Executive Director
|
125,000
+92.8%
23.96
USD 2,995,000
|
125,000
+92.8%
|
23.96
|
USD 2,995,000
|
|
|
2018-07-03 |
2018-05-15 |
B
Purchase
|
DE SCHUTTER RICHARD U
Non-Executive Director
|
10,000
+inf%
21.80
USD 218,000
|
10,000
+inf%
|
21.80
|
USD 218,000
|
|
|
2018-05-17 |
2018-05-15 |
B
Purchase
|
DE SCHUTTER RICHARD U
Non-Executive Director
|
15,000
+12.7%
21.83
USD 327,450
|
15,000
+12.7%
|
21.83
|
USD 327,450
|
|
|
2018-03-13 |
2018-03-13 |
B
Purchase
|
Herendeen Paul
EVP and CFO
|
15,000
+6.9%
16.10
USD 241,470
|
15,000
+6.9%
|
16.10
|
USD 241,470
|
|
|
2018-03-13 |
2018-03-13 |
B
Purchase
|
PAPA JOSEPH C
CHAIRMAN & CEO
Executive Director
|
30,000
+4.4%
16.05
USD 481,500
|
30,000
+4.4%
|
16.05
|
USD 481,500
|
|
|
2018-03-12 |
2018-03-08 |
B
Purchase
|
DE SCHUTTER RICHARD U
|
10,000
+10.4%
15.34
USD 153,400
|
10,000
+10.4%
|
15.34
|
USD 153,400
|
|
|
2018-03-08 |
2018-03-06 |
B
Purchase
|
Paulson John
|
7,066,629
+51.3%
15.40
USD 108,826,087
|
7,066,629
+51.3%
|
15.40
|
USD 108,826,087
|
|
|
2018-03-08 |
2018-03-06 |
S
Sale
|
Paulson John
|
7,066,629
-33.9%
15.40
USD 108,826,087
|
7,066,629
-33.9%
|
15.40
|
USD 108,826,087
|
|
|
2017-11-21 |
2017-11-17 |
B
Purchase
|
DE SCHUTTER RICHARD U
|
10,000
+11.8%
14.33
USD 143,300
|
10,000
+11.8%
|
14.33
|
USD 143,300
|
|
|
2017-11-20 |
2017-11-16 |
S
Sale
|
Paulson John
|
344,216
-1.6%
14.39
USD 4,952,821
|
344,216
-1.6%
|
14.39
|
USD 4,952,821
|
|
|
2017-11-20 |
2017-11-16 |
B
Purchase
|
Paulson John
|
344,216
+1.7%
14.40
USD 4,955,506
|
344,216
+1.7%
|
14.40
|
USD 4,955,506
|
|
|
2017-08-22 |
2017-08-21 |
B
Purchase
|
DE SCHUTTER RICHARD U
|
4,900
+6.3%
14.35
USD 70,315
|
4,900
+6.3%
|
14.35
|
USD 70,315
|
|
|
2017-08-22 |
2017-08-21 |
B
Purchase
|
DE SCHUTTER RICHARD U
|
5,100
+7.0%
14.31
USD 72,981
|
5,100
+7.0%
|
14.31
|
USD 72,981
|
|
|
2017-05-15 |
2017-05-11 |
B
Purchase
|
DE SCHUTTER RICHARD U
Non-Executive Director
|
20,000
+39.5%
13.90
USD 278,000
|
20,000
+39.5%
|
13.90
|
USD 278,000
|
|
|
2017-03-16 |
2017-03-15 |
B
Purchase
|
DE SCHUTTER RICHARD U
Non-Executive Director
|
10,000
+65.8%
10.80
USD 108,000
|
10,000
+65.8%
|
10.80
|
USD 108,000
|
|
|
2017-03-16 |
2017-03-14 |
B
Purchase
|
Herendeen Paul
EVP and CFO
|
24,000
+16.0%
10.72
USD 257,280
|
24,000
+16.0%
|
10.72
|
USD 257,280
|
|
|
2017-03-16 |
2017-03-14 |
B
Purchase
|
ValueAct Holdings, L.P.
See Remarks
|
2,500,000
+17.3%
10.81
USD 27,025,000
|
2,500,000
+17.3%
|
10.81
|
USD 27,025,000
|
|
